FinBERT, a financial-language model, scores this headline as positive (96% confidence). That is the news tone only — not the full stock rating.
Stocks › SHC
Sotera Health Co (SHC) stock analysis
WEAK BUY 22% confidence · analysed Nov 3, 2026
On Nov 3, 2026, our model rated Sotera Health Co (SHC) WEAK BUY with 22% confidence at a price of $17.74. That means the signals lean positive, but they are mixed, so conviction is low.
Analysed price$17.74
Technical picture
The 14-day RSI is 44. Momentum is soft: below the neutral 50 line, but not yet oversold.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price has slipped below its 50-day moving average but is still above the 200-day: a pullback inside a longer-term uptrend.
Volume is about normal (1.5x the 20-day average).
Trend structure and money flow
Market structure: bearish structure intact, no fresh break.
The most recent swing high is $19.79 and the swing low is $13.09; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The PEG ratio is 1.31, which looks reasonably priced for its growth.
The company reports a profit margin of 13.4% and revenue growth of +9.2%.
In its latest quarter it earned $0.26 per share, which beat the $0.24 analysts expected, with revenue +9.2% year over year.
Wall Street's average rating is 1.8 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $22.61.
The next earnings report is expected around Nov 3, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $17.74, a target of $18.62 (+5.0%) and a stop-loss at $16.69 (-5.9%).
That is a reward-to-risk ratio of about 0.8 to 1: the potential loss is bigger than the gain, a weak setup.
The plan has a time limit: reassess by Nov 13, 2026 whatever the price does.
Entry$17.74
Target$18.62
Stop-loss$16.69
Reassess byNov 13, 2026
The model's one-paragraph read
Leans BUY — composite score +0.22 (WEAK BUY). Technicals: RSI 43.56, MACD bullish, price below SMA50. Fundamentals: PEG 1.31, margin 13.4%, revenue growth 9.2%. Financial results: YoY revenue +9.2%, last EPS surprise +8.3%, next earnings 2026-11-03. Smart Money Concepts: bearish structure intact, no fresh break, price retesting a bullish order block. FinGPT news read: positive. Suggested levels: entry $17.74, target $18.62, stop-loss $16.69, exit by 2026-11-13 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for SHC
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 3, 2026 | WEAK BUY | 22% | $17.74 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on SHC
Nov 3, 2026 · Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
- Nov 3, 2026: Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results (GlobeNewswire)
Frequently asked questions
Is SHC a buy right now?
As of Nov 3, 2026, our automated model rates Sotera Health Co (SHC) WEAK BUY with 22% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for SHC?
The model's most recent plan targets $18.62 with a stop-loss at $16.69, from an entry near $17.74.
When does Sotera Health Co report earnings next?
The next earnings report is expected around Nov 3, 2026.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.